FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
16 letters match. Newest first.
-
DrugsDesBio/Deseret Biologicals, Inc.
FDA says DesBio’s CHLA:10M, sold online for Chlamydia symptoms, is an unapproved new drug.
High risk -
DrugsRoyal Peptides LLC
FDA warned Royal Peptides LLC that seven peptide products sold on its website are unapproved new drugs.
High risk -
DrugsImmunityBio, Inc.
FDA says ImmunityBio's Anktiva TV ad and podcast falsely claim it can cure or prevent all cancers.
High risk -
BiologicsCSL Behring
FDA says CSL Behring's HIZENTRA TV ad overstates protection and plays down risks, misbranding the immune globulin biologic.
Medium -
DrugsEli Lilly and Company
FDA says Eli Lilly’s Oprah-linked video for Zepbound and Mounjaro misled on serious risks.
High risk -
DrugsNovo Nordisk Inc.
FDA says Novo Nordisk’s Oprah Winfrey video makes Wegovy, Ozempic and Victoza look safer than their labels allow.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly's Zepbound online video omitted risk and limitations information and was not submitted to FDA.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly's sponsored Zepbound video omitted risk and use information, misbranding the drug.
Low -
DevicesReset Technology Corporation
FDA warns Reset Technology about missing validation and complaint handling for ResetSmile dental devices.
High risk -
BiologicsHuman Microbes
FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.
High risk -
DevicesVivera Pharmaceuticals, Inc.
Vivera Pharmaceuticals sold a COVID-19 home specimen collection kit directly to consumers without FDA approval, clearance, or authorization.
High risk -
DevicesBiopolygen Corp.
FDA warned Biopolygen Corp. for selling three unapproved COVID-19 self-test kits directly to consumers online.
High risk -
DevicesBaltimore Beauty Security Square Mall
Baltimore Beauty offered GenBody COVID-19 test kits directly to consumers without FDA approval, clearance, or authorization.
High risk -
DevicesFast Masks USA LLC
Fast Masks USA sold unapproved at-home COVID-19 test kits and claimed they were FDA approved or authorized, FDA says.
High risk -
DevicesTresmonet Technologies, Inc., TM Testing, Inc. dba TM Technologies, Inc./TM Labs
FDA warned Tresmonet/TM Labs over selling an unapproved, misbranded at-home COVID-19 antibody test and claiming FDA approval.
High risk -
DrugsCooperSurgical, Inc.
FDA says CooperSurgical’s Paragard video omitted all risk information, making the birth-control promotion misleading and misbranded.
Low